<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2014-1-27-34</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ИНТЕНСИВНОСТЬ ПРОЦЕССОВ АПОПТОЗА И ПРОЛИФЕРАЦИИ ЛИМФОЦИТОВ В УСЛОВИЯХ ДИСЛИПИДЕМИИ ПРИ РАННИХ ФОРМАХ ХРОНИЧЕСКОЙ ИШЕМИИ МОЗГА</article-title><trans-title-group xml:lang="en"><trans-title>INTENSITY OF APOPTOTIC AND PROLIFERATIVE EVENTS IN LYMPHOCYTES UNDER DYSLIPIDEMIC CONDITIONS AT EARLY STAGES OF CHRONIC BRAIN ISCHEMIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зурочка</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zurochka</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, ФГБУН«Институт иммунологии и физиологии» УрО РАН</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor,Research Institute of Immunology and Physiology,Russian Academy of Sciences, Ural Branch</p></bio><email xlink:type="simple">v_zurochka@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давыдова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Davydova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший преподавателькафедры патофизиологии ГБОУ ВПО «Южно-Уральский государственный медицинскийуниверситет», г. Челябинск</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Lecturer,Department of Pathophysiology, South Ural StateMedical University, Chelyabinsk</p></bio><email xlink:type="simple">v_zurochka@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Альтман</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Altman</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>профессор кафедрыневрологии ГБОУ ВПО «Южно-Уральскийгосударственный медицинский университет»,г. Челябинск</p></bio><email xlink:type="simple">v_zurochka@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУН «Институт иммунологии и физиологии» УрО РАН, г. Екатеринбург<country>Россия</country></aff><aff xml:lang="en">Research Institute of Immunology and Physiology, Russian Academy of Sciences, Ural Branch, Ekaterinburg<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ГБОУ ВПО «Южно-Уральский государственный медицинский университет», г. Челябинск<country>Россия</country></aff><aff xml:lang="en">South Ural State Medical University, Chelyabinsk<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>05</day><month>07</month><year>2014</year></pub-date><volume>16</volume><issue>1</issue><fpage>27</fpage><lpage>34</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зурочка А.В., Давыдова Е.В., Альтман Д.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Зурочка А.В., Давыдова Е.В., Альтман Д.А.</copyright-holder><copyright-holder xml:lang="en">Zurochka A.V., Davydova E.V., Altman D.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/19">https://www.mimmun.ru/mimmun/article/view/19</self-uri><abstract/><trans-abstract xml:lang="en"><p>Incidence of different types of dislipoproteinemias (DLPs) and a balance between apoptosis andproliferation of lymphocytes were studied in males exhibiting initial manifestations of cerebral blood flowinsufficiency (ICBI). In general, high intensity of lymphocyte activation was revealed in patients with ICBI,with amplified proliferative potential demonstrable in this group. We have also shown a trend to increasednumbers of T and B lymphocytes expressing antiapoptogenic bcl-2 protein. The changes in apoptosis and cellproliferation intensity were more pronounced in IIA and IIB types of DLP. In these groups, unidirectionalchanges of FasR expression were observed. However, the parameters reflecting readiness to apoptosis werechanged multidirectionally. Cholesterol and oxysterols transported to the cells under excessive dyslipidemiamay influence activities of transcription factor genes (bcl-2, Fas-regulatory gene (TDAG51), thus, probably,causing an imbalance between cellular proliferation and apoptosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>начальные проявления недостаточности кровоснабжения мозга</kwd><kwd>дислипидемия</kwd><kwd>апоптоз</kwd><kwd>пролиферация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>initial manifestation of insufficient blood supply to the brain</kwd><kwd>dyslipidemia</kwd><kwd>apoptosis</kwd><kwd>cell proliferation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Виленский Б.С., Семенова Г.М., Широков Е.А. Патокинез сосудистых поражений мозга // Журнал неврологии и психиатрии им. Корсакова. – 2000. – Т. 100, № 3. – С. 14-18. Vilenskiy B.S., Semenova G.M., Shirokov E.A. Patokinez sosudistykh porazheniy mozga [Patokinez vascular lesions of the brain]. Zhurnal nevrologii i psikhiatrii im. Korsakova – Korsakov Journal of Neurology and Psychiatry, 2000, vol. 100, no. 3, pp. 14-18.</mixed-citation><mixed-citation xml:lang="en">Виленский Б.С., Семенова Г.М., Широков Е.А. Патокинез сосудистых поражений мозга // Журнал неврологии и психиатрии им. Корсакова. – 2000. – Т. 100, № 3. – С. 14-18. Vilenskiy B.S., Semenova G.M., Shirokov E.A. Patokinez sosudistykh porazheniy mozga [Patokinez vascular lesions of the brain]. Zhurnal nevrologii i psikhiatrii im. Korsakova – Korsakov Journal of Neurology and Psychiatry, 2000, vol. 100, no. 3, pp. 14-18.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Доборджгинидзе Л.М., Грацианский Н.А. Дислипидемии: липиды и липопротеины, метаболизм и участие в атерогенезе // Российский медицинский журнал. – 2000. – Т. 8, № 7. – C. 269-275. Dobordzhginidze L.M., Gratsianskiy N.A. Dislipidemii: lipidy i lipoproteiny, metabolizm i uchastie v aterogeneze [Dyslipidemia: lipids and lipoproteins, metabolism and participate in atherogenesis]. Rossiyskiy meditsinskiy zhurnal – Russian Medical Journal, 2000, vol. 8, no. 7, pp. 269-275.</mixed-citation><mixed-citation xml:lang="en">Доборджгинидзе Л.М., Грацианский Н.А. Дислипидемии: липиды и липопротеины, метаболизм и участие в атерогенезе // Российский медицинский журнал. – 2000. – Т. 8, № 7. – C. 269-275. Dobordzhginidze L.M., Gratsianskiy N.A. Dislipidemii: lipidy i lipoproteiny, metabolizm i uchastie v aterogeneze [Dyslipidemia: lipids and lipoproteins, metabolism and participate in atherogenesis]. Rossiyskiy meditsinskiy zhurnal – Russian Medical Journal, 2000, vol. 8, no. 7, pp. 269-275.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Барышников А.Ю., Шишкин Ю.В. Иммунологические проблемы апоптоза. – М.: Эдиториал УРСС, 2002. – 320 с. Baryshnikov A.YU., Shishkin YU.V. Immunologicheskie problemy apoptoza [Immunological problems apoptosis]. Moscow, Editorial URSS, 2002. 320 p.</mixed-citation><mixed-citation xml:lang="en">Барышников А.Ю., Шишкин Ю.В. Иммунологические проблемы апоптоза. – М.: Эдиториал УРСС, 2002. – 320 с. Baryshnikov A.YU., Shishkin YU.V. Immunologicheskie problemy apoptoza [Immunological problems apoptosis]. Moscow, Editorial URSS, 2002. 320 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Рисберг В.Ю. Особенности иммунного статуса и апоптоз лимфоцитов при опийной наркомании: автореферат дис. канд. мед. наук. – Челябинск, 2002. – 250 с. Risberg V.Yu. Osobennosti immunnogo statusa i apoptoz limfotsitov pri opiynoy narkomanii. Avtoreferat dis. kand. med. nauk [Features of the immune status and apoptosis of lymphocytes in opioid addiction. Cand. med. sci. diss.]. Chelyabinsk, 2002. 250 p.</mixed-citation><mixed-citation xml:lang="en">Рисберг В.Ю. Особенности иммунного статуса и апоптоз лимфоцитов при опийной наркомании: автореферат дис. канд. мед. наук. – Челябинск, 2002. – 250 с. Risberg V.Yu. Osobennosti immunnogo statusa i apoptoz limfotsitov pri opiynoy narkomanii. Avtoreferat dis. kand. med. nauk [Features of the immune status and apoptosis of lymphocytes in opioid addiction. Cand. med. sci. diss.]. Chelyabinsk, 2002. 250 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга // Журнал невропатологии и психиатрии. – 1985. – № 9. – С. 1281-1288. Shmidt E.V. Klassifikatsiya sosudistykh porazheniy golovnogo i spinnogo mozga [Classification of vascular lesions of the brain and spinal cord]. Zhurnal nevropatologii i psikhiatrii – J. of Neurology and Psychiatry, 1985, no. 9, pp. 1281-1288.</mixed-citation><mixed-citation xml:lang="en">Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга // Журнал невропатологии и психиатрии. – 1985. – № 9. – С. 1281-1288. Shmidt E.V. Klassifikatsiya sosudistykh porazheniy golovnogo i spinnogo mozga [Classification of vascular lesions of the brain and spinal cord]. Zhurnal nevropatologii i psikhiatrii – J. of Neurology and Psychiatry, 1985, no. 9, pp. 1281-1288.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tricot O., Mallat Z., Heymes C. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation, 2000, vol. 101, no. 21, pp. 2450-2453.</mixed-citation><mixed-citation xml:lang="en">Tricot O., Mallat Z., Heymes C. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation, 2000, vol. 101, no. 21, pp. 2450-2453.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chang M.K., Bergmark C., Laurila A. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA., 1999, vol. 96, no. 11, pp. 6353-6358.</mixed-citation><mixed-citation xml:lang="en">Chang M.K., Bergmark C., Laurila A. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA., 1999, vol. 96, no. 11, pp. 6353-6358.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Carmelet P., Lampugnani M.G., Moons L. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell, 1999, vol. 98, no. 2, pp. 147-157.</mixed-citation><mixed-citation xml:lang="en">Carmelet P., Lampugnani M.G., Moons L. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell, 1999, vol. 98, no. 2, pp. 147-157.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Candipan R.C., Wang B., Buitrago R. Regression or progression: dependency on vascular nitric oxide. Arterioscler. Thromb. Vasc. Biol., 1996, vol. 16, no. 1, pp. 44-50.</mixed-citation><mixed-citation xml:lang="en">Candipan R.C., Wang B., Buitrago R. Regression or progression: dependency on vascular nitric oxide. Arterioscler. Thromb. Vasc. Biol., 1996, vol. 16, no. 1, pp. 44-50.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Q. Role of Heat Shock Proteins in Atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2002, vol. 22, no. 10, pp. 1547-1559.</mixed-citation><mixed-citation xml:lang="en">Xu Q. Role of Heat Shock Proteins in Atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2002, vol. 22, no. 10, pp. 1547-1559.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Krammer P. CD95’s deadly mission in the immune system. Nature, 2000, vol. 407, no. 6805, pp. 789-800.</mixed-citation><mixed-citation xml:lang="en">Krammer P. CD95’s deadly mission in the immune system. Nature, 2000, vol. 407, no. 6805, pp. 789-800.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sibiryak S., Risberg V., Yusupova R. The immune status and lymphocyte apoptosis in the opioid addicts. Rus. J. Immunol., 2001, vol. 6, no. 3, pp. 282-290.</mixed-citation><mixed-citation xml:lang="en">Sibiryak S., Risberg V., Yusupova R. The immune status and lymphocyte apoptosis in the opioid addicts. Rus. J. Immunol., 2001, vol. 6, no. 3, pp. 282-290.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sponne I., Fifre A., Kriem B. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid-Ab peptide. FASEB J., 2004, vol. 18, no. 7, pp. 836-838.</mixed-citation><mixed-citation xml:lang="en">Sponne I., Fifre A., Kriem B. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid-Ab peptide. FASEB J., 2004, vol. 18, no. 7, pp. 836-838.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
